Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Mitigation Strategies and Compliance in the Covid-19 Fight; How Much Compliance is Enough?

Swati Mukerjee, Clifton Chow, Mingfei Li
doi: https://doi.org/10.1101/2020.09.07.20189449
Swati Mukerjee
1Department of Economics, Bentley University, Waltham, MA, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: smukerjee{at}bentley.edu
Clifton Chow
2Academic Technology Center, Bentley University, Waltham, MA, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mingfei Li
3Department of Mathematical Sciences, Bentley University, Waltham, MA, United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Today, with only 4% of the world’s population, the U.S. is bearing a disproportionate share of COVID-19 infections. Seeking to understand this puzzle, we investigate how mitigation strategies and compliance can work together (or in opposition) to reduce (or increase) the spread of COVID-19 infection. Drilling down to the state level, we create specific state indices suitable for the U.S. to measure the degree of strictness of public mitigation measures. In this, we build on the Oxford Stringency Index. A modified time-varying SEIRD model, incorporating this Stringency Index as well as a Compliance Indicator to reduce the transmission, is then estimated with daily data for a sample of 6 U.S. states. These are New York, New Hampshire, New Mexico, Colorado, Texas, and Arizona. We provide a simple visual policy tool to evaluate the various combinations of mitigation policies and compliance that can reduce the basic reproduction number to less than one; this is the acknowledged threshold in the epidemiological literature to control the pandemic. States successful in combating the pandemic were able to achieve a suitable combination. Understanding of this relationship by the public and policy makers is key to controlling the pandemic. This tool has the potential to be used in a real-time, dynamic fashion for flexible policy options.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This paper is not supported by any funding.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This paper is based on public data. There is no human subjects or any clinical trials involved.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All the data used in this paper are public data. All the data resources are listed in the reference list in this manuscript.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted September 09, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Mitigation Strategies and Compliance in the Covid-19 Fight; How Much Compliance is Enough?
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Mitigation Strategies and Compliance in the Covid-19 Fight; How Much Compliance is Enough?
Swati Mukerjee, Clifton Chow, Mingfei Li
medRxiv 2020.09.07.20189449; doi: https://doi.org/10.1101/2020.09.07.20189449
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Mitigation Strategies and Compliance in the Covid-19 Fight; How Much Compliance is Enough?
Swati Mukerjee, Clifton Chow, Mingfei Li
medRxiv 2020.09.07.20189449; doi: https://doi.org/10.1101/2020.09.07.20189449

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Health Policy
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)